Trinity Biotech (TRIB) Amortization (2009 - 2021)
Trinity Biotech's (TRIB) quarterly Amortization came in at $242.3 million in Q4 2021, down 3.26% year-on-year from $250.4 million in Q4 2020, and down 3.26% quarter-over-quarter from $250.4 million in Q4 2020.
Trinity Biotech (TRIB) Amortization (2009 - 2021) Analysis & Trends
Trinity Biotech has disclosed Amortization across 3 years of filings, most recently posting $242.3 million for Q4 2021.
- Amortization for Q4 2021 came in at $242.3 million, down 3.26% year-over-year; the trailing twelve-month figure through Jun 2009 was $302009.0 (changed N/A YoY), and the FY2021 annual result was $242.3 million, down 3.26% from the prior year.
- Amortization came in at $242.3 million for Q4 2021 at Trinity Biotech, down from $250.4 million in the prior quarter.
- In the past five years, Amortization ranged from a high of $250.4 million in Q4 2020 to a low of $242.3 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 242.26 Mn |
| Dec 31, 2021 | 242.26 Mn |
| Dec 31, 2020 | 250.42 Mn |
| Dec 31, 2020 | 250.42 Mn |
| Jun 30, 2009 | 302,009.00 |
| Jun 30, 2009 | 302,009.00 |
| Mar 31, 2009 | 312,009.00 |
| Mar 31, 2009 | 312,009.00 |